Founded in 1992, Trinity Biotech plc is a global developer and marketer of diagnostic products aimed at the point-of-care, self-testing, and clinical laboratory segments. The company's core mission is to improve healthcare outcomes through innovative diagnostic solutions. Trinity Biotech offers a wide range of products, including rapid tests for infectious diseases, hemoglobin tests, and autoimmune diagnostics. Their market focus spans worldwide distribution through international distributors and strategic partners.
Notable affiliated people include co-founder Ronan O’Caoimh, who has played a significant role in the company's strategic direction. Trinity Biotech has achieved key milestones such as FDA approvals for several of its diagnostic tests and expansion into over 75 countries. The company has made a substantial impact on global healthcare by providing reliable and accessible diagnostic tools, contributing to better disease management and patient care.
